| EGFR | EGFR | TK | 7u9a | A | | 4-(5-chloro-4-fluoro-2-hydroxyanilino)-7-methoxyquinazolin-6-ol | Human | 14527 | 0.48 | |
| MAPK14 (p38a) | MAPK | CMGC | 1di9 | A | | 4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline | Human | 5251 | 0.70 | |
| EGFR | EGFR | TK | 4lrm | B | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 867 | 0.45 | |
| EGFR | EGFR | TK | 4ll0 | A | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 804 | 0.45 | |
| AURKA (AurA) | Aur | Other | 2c6e | A | | n-{5-[(7-{[(2s)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}-6-methoxyquinazolin-4-yl)amino]pyrimidin-2-yl}benzamide | Human | 1989 | 0.46 | |
| EGFR | EGFR | TK | 4hjo | A | | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 835 | 0.55 | |
| EGFR | EGFR | TK | 4ll0 | B | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 796 | 0.45 | |
| EGFR | EGFR | TK | 4lrm | C | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 781 | 0.45 | |
| EGFR | EGFR | TK | 7a6j | A | B | 1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one | Human | 14124 | 0.42 | |
| MERTK (MER) | Axl | TK | 7avy | A | | n-(2-(2-cyclopropylethoxy)pyrimidin-5-yl)-7-methoxy-6-(piperidin-4-ylmethoxy)quinazolin-4-amine | Human | 13369 | 0.43 | |
| EGFR | EGFR | TK | 1m17 | A | B | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 905 | 0.55 | |
| EGFR | EGFR | TK | 3ug2 | A | A | gefitinib | Human | 898 | 0.45 | |
| EGFR | EGFR | TK | 7a6j | A | A | 1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one | Human | 14125 | 0.42 | |
| EGFR | EGFR | TK | 2ity | A | | gefitinib | Human | 790 | 0.45 | |
| GAK | NAK | Other | 5y80 | A | A | gefitinib | Human | 10329 | 0.45 | |
| GAK | NAK | Other | 5y7z | A | | gefitinib | Human | 10332 | 0.45 | |
| GAK | NAK | Other | 5y80 | A | B | gefitinib | Human | 10330 | 0.45 | |
| TTBK2 | TTBK | CK1 | 6u0k | B | A | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12049 | 1.00 | |
| TTBK2 | TTBK | CK1 | 6u0k | A | A | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12046 | 1.00 | |
| CDK2 | CDK | CMGC | 1di8 | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 4577 | 1.00 | |
| GAK | NAK | Other | 5y7z | B | | gefitinib | Human | 10331 | 0.45 | |
| EPHB3 (EphB3) | Eph | TK | 5l6p | A | | ~{n}-(4-phenylazanylquinazolin-7-yl)ethanamide | Human | 6937 | 0.46 | |
| EGFR | EGFR | TK | 2j5f | A | | n-[4-(3-bromo-phenylamino)-quinazolin-6-yl]-acrylamide | Human | 862 | 0.44 | |
| ABL1 | Abl | TK | 8ssn | A | | 6,7-dimethoxy-n-(4-phenoxyphenyl)quinazolin-4-amine | Human | 14878 | 0.64 | |
| EPHB3 (EphB3) | Eph | TK | 5l6o | A | | 1-(4-phenylazanylquinazolin-7-yl)ethanone | Human | 6938 | 0.47 | |
| EGFR | EGFR | TK | 8f1y | A | | 1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one | Human | 14940 | 0.42 | |
| EGFR | EGFR | TK | 8f1w | A | | 1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one | Human | 14944 | 0.42 | |
| PIK3CG (p110g) | PIK | Atypical | 3qaq | A | | [(4-{2-[(3-hydroxyphenyl)amino]-1h-benzimidazol-1-yl}-1,3,5-triazin-2-yl)amino]acetonitrile | Human | 9211 | 0.41 | |
| EGFR | EGFR | TK | 4i22 | A | | gefitinib | Human | 823 | 0.45 | |
| EGFR | EGFR | TK | 4lrm | D | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 786 | 0.45 | |
| EGFR | EGFR | TK | 4wkq | A | A | gefitinib | Human | 889 | 0.45 | |
| EGFR | EGFR | TK | 4lrm | A | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 901 | 0.45 | |
| EGFR | EGFR | TK | 4lrm | E | | n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}propanamide | Human | 825 | 0.45 | |
| EGFR | EGFR | TK | 3ug2 | A | B | gefitinib | Human | 819 | 0.45 | |
| EGFR | EGFR | TK | 2ito | A | | gefitinib | Human | 783 | 0.45 | |
| EGFR | EGFR | TK | 2itz | A | | gefitinib | Human | 789 | 0.45 | |
| AURKA (AurA) | Aur | Other | 2c6e | B | | n-{5-[(7-{[(2s)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}-6-methoxyquinazolin-4-yl)amino]pyrimidin-2-yl}benzamide | Human | 2046 | 0.46 | |
| KDR | VEGFR | TK | 2p2h | A | | 4-(2-anilinopyridin-3-yl)-n-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine | Human | 5310 | 0.42 | |
| RET | Ret | TK | 5amn | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 6412 | 1.00 | |
| KSR2 | RAF | TKL | 5kkr | B | | 6,7-dimethoxy-~{n}-(2-methyl-4-phenoxy-phenyl)quinazolin-4-amine | Human | 7027 | 0.52 | |
| TTBK1 | TTBK | CK1 | 4btk | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 771 | 1.00 | |
| RET | Ret | TK | 2ivu | A | | 4-bromo-2-fluoro-n-[(4e)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4(1h)-ylidene]aniline | Human | 3364 | 0.41 | |
| EGFR | EGFR | TK | 4wkq | A | B | gefitinib | Human | 837 | 0.45 | |
| EGFR | EGFR | TK | 1m17 | A | A | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 873 | 0.55 | |
| EGFR | EGFR | TK | 4lqm | A | | n-[4-(3-bromo-phenylamino)-quinazolin-6-yl]-acrylamide | Human | 785 | 0.44 | |
| TTBK2 | TTBK | CK1 | 6u0k | B | B | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12047 | 1.00 | |
| TTBK2 | TTBK | CK1 | 6u0k | A | B | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12048 | 1.00 | |